XML 89 R38.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENTS (Details Narrative)
1 Months Ended 6 Months Ended
Jul. 16, 2018
USD ($)
shares
May 17, 2018
USD ($)
shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2020
EUR (€)
Jun. 30, 2020
CAD ($)
Dec. 31, 2019
USD ($)
Jun. 30, 2019
Sep. 27, 2013
Net unrealized loss on fair value investment     $ 3,254          
Marketable securities - Divsersa S.A. [Member]                
Closing price of shares | $ / shares     $ 5.01          
Shares issued as marketable securities | shares     40,000          
Marketable securities - National Bank of Greece [Member]                
Closing price of shares | $ / shares     $ 0.14          
Marketable securities     $ 2,080          
Shares issued as marketable securities | shares     16,666          
Stock issued during the period, amount     $ 200,468          
Cosmo Farmacy LP [Member]                
Investement     $ 168,555          
Initial share capital | €       € 150,000        
Initial share capital increased | €       500,000        
Pharmacy license value | €       € 350,000        
Maturity period of license     30 years 30 years 30 years      
Ownership equity             70.00%  
cash contributed to limited partner | €       € 150,000        
Equity ownership remaining             30.00%  
Kaneh Bosm Biotechnology Inc [Member] | Share Exchange Agreement [Member]                
Transfer of shares | shares   2,500,000            
Kaneh Bosm Biotechnology Inc [Member] | Share Exchange Agreement [Member] | Canadian Securities Exchange [Member]                
Exchange of shares | shares   5,000,000            
Share Exchange Agreement [Member] | Amplerissimo Ltd [Member]                
Ownership equity               100.00%
Share Exchange Agreement [Member] | ICC [Member]                
Net unrealized loss on fair value investment     $ 13,500          
Investement     $ 46,500     $ 33,000    
Equity method investment shares acquired | shares 5,000,000              
Description for ownership percentage The ten million shares of ICC owned by the Company constituted approximately 7% of the 141,219,108 shares of capital stock of KBB then issued and outstanding. The Company does not have the ability to exercise significant influence over ICC              
Additional shares issued | shares     3,000,000          
Share Exchange Agreement [Member] | Marathon Global Inc [Member]                
Shares of Marathon transferred by company to KBB | shares 2,500,000              
Gain on exchange of investment $ 2,092,200 $ 1,953,000            
Distribution and Equity Acquisition Agreement [Member] | Marathon Global Inc [Member]                
Equity interest acquired description     a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services      
Cash received upon repayment for purchase common stock         $ 2,000,000      
Distribution and Equity Acquisition Agreement [Member] | Marathon Global Inc [Member] | Gross Sales One [Member]                
Cash received upon gross sales         2,750,000      
Gross sales         13,000,000      
Distribution and Equity Acquisition Agreement [Member] | Marathon Global Inc [Member] | Gross Sales [Member]                
Cash received upon gross sales         2,750,000      
Gross sales         $ 6,500,000